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Resuscitation from hypotensive circulatory shock is often 
more complex than just giving intravascular ﬂ  uids. Even 
in ﬂ   uid-responsive hypotensive patients, vital organ 
perfusion may remain compromised despite ﬂ  uid 
infusion if the mean arterial pressure (MAP) does not 
also increase with increasing cardiac output (CO). García 
and colleagues suggested an approach that would predict 
whether the hypotensive patient would increase their 
MAP in response to intravascular ﬂ  uid loading [1].
Th  ere is a tight correlation between positive-pressure 
ventilation-induced changes in arterial pulse pressure 
(PP), called pulse pressure variation (PPV), and ﬂ  uid 
responsiveness [2]. PPV is calculated as the ratio of 
diﬀ  erence between maximum and minimum PP to their 
mean as assessed over about 5 breaths or 20 seconds. Th  e 
greater the PPV, the greater the CO increase. Not 
surprisingly, subsequent studies showed that similarly 
calculated stroke volume variation (SVV), when measured 
independently, also predicted volume responsiveness [3]. 
Importantly, PP is created by stroke volume (SV) into the 
central arterial compartment as quantiﬁ  ed by a transfer 
function [4]. If arterial elastance (Ea) and compliance 
remain constant, then aortic PP will vary directly with 
SV. If the bedside physician wants to know whether their 
hypotensive patient will increase their MAP in response 
to ﬂ  uid loading, then they need to know two things. First, 
is the patient volume responsive? If the patient is not 
responsive, then volume loading will not increase CO. 
Second, the physician needs to know the patient’s 
vasomotor tone. If the patient has marked vasodilation, 
as commonly occurs in septic shock, then MAP may not 
increase in response to ﬂ  uid loading even if CO does.
To know whether a ﬂ   uid-responsive patient is also 
pressure responsive, one needs to assess vasomotor tone. 
Th  e relation between dynamic changes in MAP to CO 
deﬁ   nes arterial resistance. But resistance is only one 
aspect of arterial tone. Vasomotor tone is deﬁ  ned by both 
the resistance and compliance. Th   e reciprocal of com  pli-
ance is Ea, which deﬁ   nes the PP/SV relation [5]. 
Increasing vasomotor tone increases both MAP and PP 
relative to CO and SV. If one knew both PPV and SVV, 
their ratio would deﬁ   ne a dynamic Ea (Eadyn) [6]. 
Th   eoretically, MAP and PP should co-vary with changes 
in CO if the heart rate remains constant. We previously 
predicted that PPV/SVV >0.8 would deﬁ  ne  pressure-
responsive subjects if CO increased [7].
Relative to this construct, García and colleagues exam-
ined the ability of the PPV/SVV ratio, deferred to as Eadyn, 
to predict changes in MAP in 25 hypotensive patients 
with preserved volume responsiveness (deﬁ  ned as MAP 
<65 mmHg or systolic blood pressure <90 mmHg and 
SVV >10%) [1]. Using a standard 500 ml colloid ﬂ  uid 
bolus, the authors deﬁ  ned MAP responders as those with 
a >15% increase in MAP. Th   ey found that a baseline Eadyn
value >0.89 predicted >15% MAP increase after ﬂ  uid 
administration with a sensitivity of 94% (95% conﬁ  dence 
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© 2011 BioMed Central Ltdinterval = 69.8 to 99.8%) and a speciﬁ  city of 100% (95% 
conﬁ   dence interval = 66.4 to 100%). Th  eir clinically 
derived Eadyn threshold of >0.89 is remarkable similar to 
our >0.8 value based on vascular modeling. Importantly, 
as long as the PPV and SVV values are great enough to 
deﬁ  ne a slope, this relationship will remain constant and 
predictive even during spontaneous ventilation and with 
cardiac arrhythmias because Eadyn is independent of 
volume responsiveness. Since all of the commercially 
available arterial pressure-derived CO monitoring 
devices report PPV and SVV, this added Eadyn parameter 
to deﬁ  ne those patients needing vasopressors earlier in 
their management should have a signiﬁ  cant impact on 
resuscitation eﬃ   cacy.
Before embracing this approach and these ﬁ  ndings 
totally, caution needs to be used in its routine bedside 
application. Importantly, Eadyn is not a direct measure of 
Ea. Eadyn is a measure of arterial stiﬀ  ness, which is itself 
partially determined by vasomotor tone. Baseline Ea is 
not constant. Ea is lower in premenopausal women than 
in age-matched men. Ea increases with age, with the 
expression of atherosclerosis and with aortic cross-
clamping during aortic vascular procedures. For all these 
conditions, however, if SV increases then PP will also 
increase. Regrettably, MAP may not increase as much as 
PP because diastolic pressure may remain constant. 
Further  more, PP can be independently increased by 
increasing left ventricular ejection velocity [6]. To the 
extent that inotropic agents are being used, one may 
presume an increase in MAP not realized by increasing 
CO even if Eadyn >0.89.
If PPV and SVV are independently measured, then the 
clinical utility becomes manifest. Th   e above study, how-
ever, used an arterial pulse contour estimating method to 
derive CO and SVV [6], and herein rests a potential 
problem. Much attention has focused on using arterial 
pulse contour analysis devices at the bedside to measure 
CO and SVV from the arterial pulse. Unfortunately, most 
indwelling arterial catheters sample a more peripheral 
arterial pressure signal, whose waveform may be altered 
in unexpected ways as the arterial tone, pulse wave 
velocity and left ventricular contractility vary. Although 
this varia  bility in CO estimates can be readily improved 
by calibration, it will not improve the accuracy of the 
PPV/SVV relation (that is, Eadyn). Th  e Eadyn accuracy is 
intrinsic to the assumptions used by each device to 
estimate SVV. Th  is is because PPV can be measured 
directly and is accurate when compared with PPV 
measured manually [8].
All arterial pressure-sensing devices that estimate CO 
do so by assuming a constant Ea. How, then, is it possible 
for an algorithm that uses arterial pressure to calculate 
CO to show diﬀ  ering changes in PP relative to SV over 
time? Th   is is the Achilles’ heel of all these pulse contour 
monitoring devices. Th   e three major commercially 
available monitoring devices, however, do not share the 
same shoe size – the variance amongst these devices to 
estimate changing CO is signiﬁ  cant [9].
García and colleagues used the FloTrac® device to make 
their Eadyn measures. Th   e FloTrac® device estimates SVV 
from the standard deviation of the individual arterial 
pressure values over single beats averaged over 
20  seconds. Assuming the SV variance has a normal 
distri  bu  tion, this assumption is valid for calculating SVV. 
Importantly,   SVV as a time-series function may not be 
normally distributed during atrial ﬁ  brillation and with 
vigorous spontaneous inspiratory eﬀ   orts. How much 
error such non-normal distribution would introduce into 
the SVV calculation is not known, but on theoretical 
modeling the degree of non-normal distribution would 
need to be great for it to aﬀ  ect SVV by the standard 
deviation method.
Th   e other two devices are the PiCCO and the LiDCO. 
Th  e PiCCO uses a proprietary algorithm based on the 
ventriculo-arterial coupling transfer function [3] to 
calculate CO. Th  is CO estimate is averaged over 20 to 
30 seconds and is quite accurate [9]. However, since the 
PiCCO no longer reports individual SV values on a beat-
to-beat basis, it is unclear how it derives SVV. Th  e 
LiDCO uses a simple power transfer function to estimate 
SV on a beat-to-beat basis and calculates CO from the 
mean SV values. To the extent that this power transfer 
function is accurate over time, the SVV estimates should 
also be accurate. Since this device does not use the pulse 
contour, the LiDCO remains accurate with dampened 
arterial pressure signals.
Accordingly, although each device reports PPV and 
SVV values, the cross-correlation amongst devices based 
on their diﬀ  erent algorithms is poor [9]. Validation of 
Eadyn thus needs to be done independently both for each 
device and for diﬀ  erent types of patients before this new 
bedside parameter is used for clinical decision-making.
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